California residents 65 and older now qualify for COVID-19 vaccinations. Questions about the mRNA Covid-19 vaccines still remain. Vaccine expert Dr. David Lo, a distinguished professor of biomedical sciences and senior associate dean for research in the School of Medicine at the University of California, Riverside, answers several questions in...

A UC Riverside-led study, funded by Merck, is set to find out

UC Riverside study examines molecular pathways that may instigate seizures in some multiple sclerosis patients

Phase 2 study investigates efficacy of the drug ecopipam developed by Emalex Biosciences Inc.

Meeting virtually with people outside your household is safest, says UC Riverside epidemiologist

Host campus UC Riverside will be joined by UC Davis and UC Merced

Neural crest study results could boost stem cell therapies

The news arrived Monday that the world has been awaiting since spring: a vaccine has been developed that shows a high degree of efficacy in late-stage trials: 90%. That puts it in the company of effective vaccines such as for measles, and well beyond what the medical community hoped for...

UC Riverside-led study describes first published survey documenting nature and extent of caregiver mistreatment of this population

UC Riverside-led study shows how variations in SARS-CoV-2 host gene expression can be linked to variations in COVID-19 susceptibility and symptom severity

Unique effects of police violence create a public health crisis for communities most affected

The UC Riverside School of Medicine's Department of Psychiatry and Neuroscience will launch a unique, first-in-the-nation sports psychiatry fellowship program. Developed in partnership with UC Riverside Intercollegiate Athletics and UCR Health, this non-ACGME program will begin accepting applications in 2021 and will start in 2022. While there are other schools...

Policy has limited impact on vaccine uptake because of individual decision making, study finds

UC Riverside-led study is the first to show how tofacitinib rescues gut barrier function from overactive immune cells

Dr. Paul Offit, an international expert on vaccines, will give the 2020 Thomas and Salma Haider Biomedical Breakthrough Lecture at UC Riverside

UC Riverside psychologist Chandra Reynolds will lead the five-year research project

UC Riverside mouse study focused on neurons in the hippocampus

A research team led by scientists at the University of California, Riverside, has outlined how the Zika virus, which constituted an epidemic threat in 2016, suppresses the immune system of its host. The Zika virus, or ZIKV, spreads through mosquito bites and sexual intercourse. Currently, no approved vaccine or antivirals...

UC Riverside researchers used a powerful machine-learning approach to screen millions of chemicals to find suitable candidates

Andrew Subica and Ann Cheney will focus their research on marginalized U.S. populations